We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Behavioral Neuroscience – Multimedia

Teach Me in 10 – Proteomics and Psychotic Disorders With Dr David Mongan content piece image
Video

Teach Me in 10 – Proteomics and Psychotic Disorders With Dr David Mongan

Can we predict psychotic disorders using a blood test? This week on Teach Me in 10, we're joined by psychiatrist and PhD student Dr David Mongan, who talks to us about proteomic prediction models for psychotic disorders and psychotic experiences.
9 Milestones From Dementia Research in 2020 content piece image
Listicle

9 Milestones From Dementia Research in 2020

This listicle addresses advances in dementia research over 2020, highlighting the strides science has made in diagnosis and treatment development.
Opinionated Science Episode 18: The No-COVID Science Wrap-Up of 2020 content piece image
Podcast

Opinionated Science Episode 18: The No-COVID Science Wrap-Up of 2020

2020 has been a memorable year in science for many reasons, most of them bad. As we finally begin to see some chinks of light at the end of this incredibly long year, the Opinionated Science team look back at some of the biggest stories of the year that were nothing to do with COVID-19, including brain implants, inherited trauma and millions of tons of microplastics.
Stanford's Professor Robert Sapolsky Lecture on Schizophrenia (Video) content piece image
Video

Stanford's Professor Robert Sapolsky Lecture on Schizophrenia (Video)

In this video, Stanford Professor Robert Sapolsky dives into a discussion about schizophrenia. He discusses environmental factors as well as genetic characteristics that could apply to people who are affected. He describes schizophrenia as a disease of thought disorder and inappropriate emotional attributes.
Opinionated Science Episode 7: The Vagus Nerve: A Target to Treat Brain and Body? content piece image
Podcast

Opinionated Science Episode 7: The Vagus Nerve: A Target to Treat Brain and Body?

In this episode, we review the evidence surrounding vagus nerve stimulation (VNS), a therapy approved for epilepsy and depression that backers now want to use to treat a host of other conditions, include autoimmune disease and heart failure. How can scientists fill in the gaps in the VNS knowledge base?
Opinionated Science Episode 2: Psychedelic Drugs: Ketamine for Depression, Party Octopuses and Stoned Dolphins content piece image
Podcast

Opinionated Science Episode 2: Psychedelic Drugs: Ketamine for Depression, Party Octopuses and Stoned Dolphins

In this episode, the Technology Networks team discusses the rejuvenated field of psychedelic drugs research and how it might provide solutions for enduring mental health disorders.
10 Books Scientists Are Reading content piece image
Listicle

10 Books Scientists Are Reading

Perlego provided us with a recent list of the top 10 books read by scientists, and it's compelling. From the legacy of autism, to deciphering the secrets of the ribosome, the list covers a wide variety of hot scientific topics.
Sleeping on the Wild Side content piece image
Listicle

The Unusual Sleeping Habits of Land and Sea Creatures

Have you ever wondered how marine mammals sleep without drowning? Whether Chimpanzees have similar nightly habits to us? And why do some animals stand when they sleep? Read on to discover some of the fascinating sleeping quirks of land and sea creatures.
Stanford's Professor Robert Sapolsky Lecture on Depression (Video)  content piece image
Video

Stanford's Professor Robert Sapolsky Depression Lecture (Video)

Stanford Professor Robert Sapolsky, posits that depression is the most damaging disease that you can experience. Right now it is the number four cause of disability in the US and it is becoming more common. Sapolsky states that depression is as real of a biological disease as is diabetes.

2019 FDA Drug Approvals content piece image
Listicle

2019 FDA Drug Approvals

This list outlines the new molecular entities (NMEs) and new therapeutic biological products approved by the FDA’s Center for Drug Evaluation and Research (CDER) during 2019.
Advertisement